Genomic analysis revealed a series of significant actionable mutation loads or pathways in gastric cancer, such as PI3K/AKT/mTOR, CLD18, and HER2/EGFR, which are likely to induce primary gastric cancer to develop into metastases6,7. Here, ERBB2 is linked to gastric cancer.